// COMPANY
Translational Development Acquisition Corp.
SECTOR FINANCEMENTIONS 2LAST SEEN MAY 28, 2026
// OVERVIEW
Translational Development Acquisition Corp. (TDAC) is a Nasdaq-listed Special Purpose Acquisition Company (SPAC) that raised $172.5 million in its IPO to serve as a blank-check vehicle for merging with a private company. It announced a $3.8 billion deal to bring Taiwan-based solid-state battery maker ProLogium Technology to public markets on Nasdaq under the ticker PRLG.
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PitchBook News·MAY 28, 2026
“Will go public at a $3.8 billion valuation via a SPAC merger with Translational Development Acquisition Corp.”
Source→02
m_and_a·Axios Pro Rata·MAY 27, 2026
“ProLogium Technology, a Taiwanese maker of solid-state batteries, agreed to go public at a $3.8b value via a merger with Translational Development Acquisition.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.